MAPKAPK5-AS1 and myositis disease: Recent developments in identifying new specificities of myositis-specific autoantibodies (MSAs), myositis-associated antibodies (MAAs), and the growing understanding of associated clinical features have led to the recognition of additional subsets of inflammatory myopathies, including anti-synthetase syndrome (ASS), immune-mediated necrotizing myopathy (IMNM), clinically amyopathic dermatomyositis (CADM), and myositis associated with overlap syndromes and cancer (2).